Q1 earnings, guidance and BetterHelp's insurance shift

Teladoc Health (TDOC) has been back in focus after Q1 2026 results and updated guidance put its BetterHelp insurance transition front and center for investors watching the virtual care stock.

The stock has seen short term momentum build, with a 30 day share price return of 25.81% and a 90 day gain of 29.75%. However, the 1 year total shareholder return of 7.27% and 3 year total shareholder return of 74.59% remain weak by comparison.

If Teladoc's recent rebound has you rethinking opportunities in virtual care and AI driven health, it can be useful to scan beyond a single stock using 33 healthcare AI stocks

With Teladoc shares still far below multi year highs yet showing a recent bounce, current pricing and an indicated 44% intrinsic discount raise the key question: is this a reset entry point, or is the market already baking in future growth?

Most Popular Narrative: 7% Undervalued

With Teladoc Health closing at $6.63 against a narrative fair value of about $7.12, the current setup revolves around muted growth expectations and how BetterHelp and Integrated Care execution might reshape the story.

Teladoc's continued investment in product innovation, including enhanced cardiometabolic programs and integrated mental health offerings, positions the company to capture growing demand for digital management of chronic diseases and leverage the increasing need for cost-effective care, supporting long-term revenue and enrollment growth.

Curious what sits behind that fair value gap? The narrative leans on modest revenue growth, a future shift in margins and a tighter earnings multiple. The mix between cash pay and insurance, plus how quickly losses narrow, does the heavy lifting in this model.

Based on this widely followed view, Teladoc is seen as modestly undervalued, yet still tied to conservative assumptions on revenue, profitability and discount rates. The discount rate of about 11% reflects a higher hurdle for future cash flows, while expected revenue growth and profit margins are set at restrained levels rather than aggressive targets, which keeps the fair value close to, but above, the current share price.

Result: Fair Value of $7.12 (UNDERVALUED)

However, the narrative could unravel if BetterHelp's shift toward lower margin insurance revenue weighs on profits or if Integrated Care growth stays muted for longer than expected.

Next Steps

With mixed signals on value, growth and execution, it helps to stress test the story against the underlying numbers and risk flags so you are not relying on a single narrative. You can review both sides of the debate in our breakdown of 3 key rewards and 1 important warning sign

Looking for more investment ideas?

If Teladoc has sharpened your focus on where capital might work harder, do not stop here. Use a broader playbook to spot opportunities others might overlook.

• Hunt for mispriced quality by scanning 48 high quality undervalued stocks that pair solid fundamentals with what may be discounted share prices.
• Prioritise resilience by reviewing 70 resilient stocks with low risk scores that score well on stability and business risk metrics.
• Get ahead of the crowd by checking the screener containing 25 high quality undiscovered gems before attention potentially shifts their way.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.